WebThus, the recently published International IgAN prediction tool could potentially provide valuable risk stratification and guide the appropriate treatment module. This study aimed to externally validate this prediction tool using a patient cohort from the IgAN registry of the Greek Society of Nephrology. Web1 jun. 2024 · We have previously developed the International IgAN Prediction Tool, which was derived and validated in multiple ethnic groups as a model to predict the risk of a …

External Validation of the International IgA Nephropathy …

WebTo investigate if treatment decisions can be more accurately accomplished using individualized risk from the International IgAN Prediction Tool, we simulated allocation of a hypothetical immunosuppression therapy in an international cohort of adults with IgAN. Web1 aug. 2024 · ; however, there is no universally accepted prediction tool for progression of IgAN. Against this background, the International IgA Nephropathy Network pooled large international IgAN cohorts (composed primarily of patients of European, Chinese, and Japanese ancestry) to derive and validate a new prediction model. food rva

Long-Term Outcomes of Patients with IgA Nephropathy …

Web1 okt. 2024 · Immunosuppression in IgA nephropathy (IgAN) should be reserved for patients at high-risk of disease progression, which KDIGO guidelines determine based solely on proteinuria 1g or more/day. To investigate if treatment decisions can be more accurately accomplished using individualized risk from the International IgAN Prediction Tool, we … http://www.bcrenal.ca/research/bc-kidney-research-in-focus/2024/updated-clinical-tool-assesses-risk-of-iga-nephropathy-progression-over-time Web18 nov. 2024 · The International IgAN Risk Prediction tool (IgAN-RPT) combines histologic lesions and clinical risk factors to predict renal outcome up to 5 or 7 years of follow-up. The clinical value beyond 7 years is unknown and microhematuria data has not been assessed. electoral commission ivote